MDC Partnership Wins Pfizer's Xalatan

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

NEW YORK Pfizer has awarded its $5 million Xalatan account to Source/Chinnici, a partnership between MDC siblings Source Marketing and Chinnici Direct.

Source/Chinnici in New York will handle brand duties as well as acquisition and customer relationship marketing for Xalatan, a prescription medication that treats glaucoma. Source Marketing in Westport, Conn., will handle account management responsibilities while Chinnici will contribute analytical capabilities, said Rich Feldman, managing partner. Creative responsibilities will be shared.

The duo defeated incumbent Pace Advertising in New York, sources said.

Separately,





AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in